StageZero Life Sciences
  • About
    • Our Story
    • Board of Directors
    • Partners
    • Library
    • Programs >
      • Telehealth
      • Employers
      • Firefighters
      • Executive Health
  • Our Science
    • The Sentinel Principle
    • Aristotle
    • ColonSentry Science
    • Publications
  • Covid-19 Testing
    • Covid-19-PCR-Saliva
    • Covid-19-PCR
    • Covid-19-Antibody
    • Respiratory Panel + COVID-19
    • Covid-19-Employers
    • Covid-19-PhysicianEnrollment
    • Frequently Asked Questions
  • Cancer Testing
    • ColonSentry Test
    • Prostate Health Index
    • BreastSentry
    • Purchase Tests
  • Physicians
    • Physician Portal
    • Establish an Account
    • Order Supplies
    • Copia Login
  • INVESTORS
    • Investor Relations
    • Press Releases
    • Events
    • In the News
    • Analyst Coverage
  • Contact
    • Customer Support
    • Corporate HQ
    • Careers
    • Bill Payment

Aristotle™

10 Cancers - One Sample of Blood
​Unlimited Possibilities

Latest News

​StageZero Life Sciences Announces Publication of Abstract at American Society of Clinical Oncology

TORONTO, ON / ACCESSWIRE / April 3, 2020 / StageZero Life Sciences, Ltd (TSX:SZLS) ("StageZero" or the "Company") today announced an abstract entitled "Aristotle: A Single Blood Test for Pan Cancer Screening" was selected for online publication at the annual meeting of the American Society of Clinical Oncology ("ASCO"). The annual meeting will be a virtual event, rather than the originally planned meeting in Chicago IL, over the time period of May 29 - June 2, 2020.
REad More

1 Test - 10 Cancers - Unlimited Possibilities

Picture
Our next-generation test, Aristotle®, is a panel for simultaneously screening for 10 cancers from a single sample of blood. Aristotle has been built on our proprietary mRNA technology platform, which was validated in more than 9,000 patients for the development of the first liquid biopsy for Colorectal Cancer (ColonSentry®). 

Early Results Show that Aristotle has a high Sensitivity and Specificity across multiple cancers
Colorectal, Prostate, Cervical, Endometrial, Breast, Ovarian, Liver, Bladder, Nasopharyngeal, and Stomach Cancer.
The multi-cancer panel platform, Aristotle, has been demonstrated to identify sets of gene transcripts capable of classifying subjects as having a specific cancer with a high degree of sensitivity and specificity. Early validation was conducted using blood samples from 788 subjects across 10 cancer types and 2,064 subjects without cancer. 
“StageZero Life Sciences, one of the pioneers of the liquid biopsy, has developed the 'holy-grail' – a suite of tests that have the correct sensitivity and specificity to detect cancer early and perform correctly as a screening tool at the population level."

​Dietrich Stephan
CEO and Founder, LifeXVentures™
Professor of Human Genomics

Aristotle’s 2-fold Cross Validation & Accuracy

These graphs demonstrate Aristotle's high Sensitivity and Specificity on ten cancers.
Picture
Picture
Picture

The First Multi-Cancer Detection Panel for Women ​


​For years, the healthcare community has been searching for a test that can find Ovarian cancer early. In fact 80% of ovarian cancers are found in the later stages. We're out to change that, not just for ovarian cancer, but for 9 of the most prevalent cancers affecting women today.  1 Sample of Blood - 9 Cancers - Found Early.
  • Bladder Cancer
  • Nasopharyngeal Cancer
  • Colorectal Cancer
  • Stomach Cancer​​​


  • Cervical Cancer
  • Endometrial Cancer
  • Breast Cancer
  • Ovarian Cancer​
  • Liver Cancer
A multi-cancer detection panel for men is in development
  • Prostate Cancer
  • Liver Cancer​
  • Bladder Cancer
  • Nasopharyngeal Cancer
  • Colorectal Cancer
  • Stomach Cancer
Looking Beyond Cancer
Our scientists are also looking to apply Aristotle to disease states in Gastroenterology, Neurology, Cardiology, and Autoimmune Disorders.
Picture
30-70 East Beaver Creek Road
Richmond Hill, Ontario L4B 3B2

8751 Park Central Drive, Suite 200
Richmond, VA 23227
​TEL: 855.420.7140 
Contact Information

Notice of Privacy Practices | Terms & Conditions | Privacy Statement & Policy | Licensing & Accreditation
  • About
    • Our Story
    • Board of Directors
    • Partners
    • Library
    • Programs >
      • Telehealth
      • Employers
      • Firefighters
      • Executive Health
  • Our Science
    • The Sentinel Principle
    • Aristotle
    • ColonSentry Science
    • Publications
  • Covid-19 Testing
    • Covid-19-PCR-Saliva
    • Covid-19-PCR
    • Covid-19-Antibody
    • Respiratory Panel + COVID-19
    • Covid-19-Employers
    • Covid-19-PhysicianEnrollment
    • Frequently Asked Questions
  • Cancer Testing
    • ColonSentry Test
    • Prostate Health Index
    • BreastSentry
    • Purchase Tests
  • Physicians
    • Physician Portal
    • Establish an Account
    • Order Supplies
    • Copia Login
  • INVESTORS
    • Investor Relations
    • Press Releases
    • Events
    • In the News
    • Analyst Coverage
  • Contact
    • Customer Support
    • Corporate HQ
    • Careers
    • Bill Payment